Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Claus

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Oncotarget|April 24, 2016
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemiaTimothy L Chen, Nikhil Gupta, Amy Lehman, et al.
Plos One|July 19, 2021
Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and multimethodological approachKlaus Hirschbühl, Sebastian Dintner, Martin Beer, et al.
International Journal of Cancer|September 19, 2017
NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinibChristine Wolf, Angela Garding, Katharina Filarsky, et al.
The Journal of Clinical Investigation|October 21, 2014
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemiaNiuscha Yaktapour, Frank Meiss, Justin Mastroianni, et al.
Haematologica|November 8, 2011
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapyMichael Lübbert, Björn H Rüter, Rainer Claus, et al.
International Journal of Cancer|September 13, 2014
DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral bloodRongxi Yang, Katrin Pfütze, Manuela Zucknick, et al.
British Journal of Haematology|July 6, 2018
Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatmentJuliane M Stosch, Anezka Heumüller, Christoph Niemöller, et al.
Blood|August 21, 2009
miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemiaChristian Philipp Pallasch, Michaela Patz, Yoon Jung Park, et al.
Cancer Discovery|December 21, 2013
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemiaChristopher C Oakes, Rainer Claus, Lei Gu, et al.
Oncoimmunology|April 14, 2017
HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapyAnnika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Oncotarget|April 24, 2016
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemiaTimothy L Chen, Nikhil Gupta, Amy Lehman, et al.
Plos One|July 19, 2021
Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and multimethodological approachKlaus Hirschbühl, Sebastian Dintner, Martin Beer, et al.
International Journal of Cancer|September 19, 2017
NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinibChristine Wolf, Angela Garding, Katharina Filarsky, et al.
The Journal of Clinical Investigation|October 21, 2014
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemiaNiuscha Yaktapour, Frank Meiss, Justin Mastroianni, et al.
Haematologica|November 8, 2011
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapyMichael Lübbert, Björn H Rüter, Rainer Claus, et al.
International Journal of Cancer|September 13, 2014
DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral bloodRongxi Yang, Katrin Pfütze, Manuela Zucknick, et al.
British Journal of Haematology|July 6, 2018
Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatmentJuliane M Stosch, Anezka Heumüller, Christoph Niemöller, et al.
Blood|August 21, 2009
miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemiaChristian Philipp Pallasch, Michaela Patz, Yoon Jung Park, et al.
Cancer Discovery|December 21, 2013
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemiaChristopher C Oakes, Rainer Claus, Lei Gu, et al.
Oncoimmunology|April 14, 2017
HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapyAnnika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, et al.
Pageof 13